Not reported
ActiveSC547221Private limited companyEdinburgh
ATEN THERAPEUTICS LTD
Significant control: Oncobiopharm Limited (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Aten Therapeutics Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Aten Therapeutics Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
ATEN THERAPEUTICS LTD is an active private limited company (company number SC547221) incorporated on 7 October 2016, registered in Edinburgh. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 30 September 2025 and cash of £33, with 0 employees on average.
There are 62 companies in research and experimental development on biotechnology in Edinburgh with filed accounts; the median reports net assets of £4,168 and is 7 years old.
02
Ownership and control
- Oncobiopharm Limited
- owns 75–100% of shares
- holds 75–100% of voting rights
- Mr Martin Alexander Quinn
- owns 75–100% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 7 October 201610 yrs ago
- Next accounts due
- 30 June 2027in 245 days
- Confirmation statement due
- 21 October 2027in 358 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£33
−92%vs Sept 2024Not reported
0
vs Sept 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 September 2025 | — | £33 | £4,886 | £138k | — | — | 0 |
| 30 September 2024 | — | £433 | £4,887 | £134k | — | — | 0 |
Current ratio0.04Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Current assets below creditors within one yearCurrent ratio 0.04
- Incorporated five or more years agoIncorporated 7 October 2016
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 358 days
- Next accounts duein 245 days
- Accounts period end
- Accounts period end
- Incorporated
08
Similar companies in Edinburgh
- ADORX THERAPEUTICS LIMITEDEdinburgh · inc. Feb 2017
- ROSLIN TECHNOLOGIES LIMITEDEaster Bush Campus · inc. Mar 2016
- CARITAS BIOSCIENCE LTDEdinburgh · inc. Dec 2015
- CYTOCHROMA LIMITEDRoslin · inc. Oct 2017
- CUMULUS ONCOLOGY LIMITEDEdinburgh · inc. Nov 2017
- ROSLIN CELL SCIENCES LIMITEDMidlothian · inc. Aug 2015
All companies incorporated on 7 October 2016 · in Oct 2016.
09
Reminders for ATEN THERAPEUTICS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.